Description:
TAY-SACHS DISEASE; TSD
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases
Lysosomal Storage Diseases |
| Class |
Disorders of Lipid Metabolism |
|
Cell Type
|
Fibroblast
|
|
Transformant
|
Untransformed
|
|
Race
|
White
|
|
Ethnicity
|
ASHKENAZI
|
|
Family Member
|
2
|
|
Relation to Proband
|
father
|
|
Confirmation
|
Clinical summary/Case history
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| Passage Frozen |
8 |
| |
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase Isoenzyme Electrophoresis |
| |
| MUTATION VERIFICATION |
Myerowitz (Proc Natl Acad Sci USA 85:3955 1988) observed 1 normal alpha chain allele and 1 alpha chain allele with a splice junction mutation consisting of a cytidine residue substituting for a guanosine as the first nucleotide at the 5 prime boundary of intron 12. Arpaia et al (NATURE 333:85-86 1988) also observed that this Tay-Sachs disease heterozygote had the same splice junction mutation a DdeI restriction site as his affected daughter (GM02968). Myerowitz and Costigan (J Biol Chem 263:18587-18589 1988) reported that this patient lacked the 4 base pair insertion in exon 11 of the alpha chain gene which was found in his spouse and affected daughter. |
| |
| Remarks |
Ashkenazi; clinically unaffected; 1 alpha chain allele has a splice junction mutation; neither alpha chain allele has a 4 bp insertion in exon 11; father of GM02968A |
| Arpaia E, Dumbrille-Ross A, Maler T, Neote K, Tropak M, Troxel C, Stirling JL, Pitts JS, Bapat B, Lamhonwah AM, et al, Identification of an altered splice site in Ashkenazi Tay-Sachs disease. Nature333:85-6 1988 |
| PubMed ID: 3362213 |
| |
| Myerowitz R, Splice junction mutation in some Ashkenazi Jews with Tay-Sachs disease: evidence against a single defect within this ethnic group. Proc Natl Acad Sci U S A85:3955-9 1988 |
| PubMed ID: 3375249 |
| |
| Myerowitz R, Costigan FC, The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase. J Biol Chem263:18587-9 1988 |
| PubMed ID: 2848800 |
| NCBI GTR |
272800 TAY-SACHS DISEASE; TSD |
| OMIM |
272800 TAY-SACHS DISEASE; TSD |
| Omim Description |
B VARIANT GM2 GANGLIOSIDOSIS |
| |
GM2-GANGLIOSIDOSIS, ADULT CHRONIC TYPE, INCLUDED |
| |
GM2-GANGLIOSIDOSIS, TYPE I |
| |
HEXA DEFICIENCYHEXOSAMINIDASE A, INCLUDED; HEXA, INCLUDED |
| |
HEXOSAMINIDASE A DEFICIENCY |
| |
HEXOSAMINIDASE A DEFICIENCY, ADULT TYPE, INCLUDED |
| |
TAY-SACHS DISEASE, JUVENILE, INCLUDED |
| |
TAY-SACHS DISEASE, PSEUDO-AB VARIANT, INCLUDED |
| |
TAY-SACHS DISEASE, VARIANT B1, INCLUDED |
| |
TAY-SACHS DISEASE; TSD |
| Passage Frozen |
8 |
| Split Ratio |
1:2 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not inactivated |
| Substrate |
None specified |
| Subcultivation Method |
trypsin-EDTA |
| Supplement |
- |
|
|